The goal of this study was to examine the effects of diseased extracellular matrix on the behavior of healthy heart cells. 
SUMMARY
Hypertrophic cardiomyopathy (HCM) is often caused by single sarcomeric gene mutations that affect muscle contraction. Pharmacological correction of mutation effects prevents but does not reverse disease in mouse models. Suspecting that diseased extracellular matrix is to blame, we obtained myocardium from a miniature swine model of HCM, decellularized thin slices of the tissue, and re-seeded them with healthy human induced pluripotent stem cell-derived cardiomyocytes. Compared with cardiomyocytes grown on healthy extracellular matrix, those grown on the diseased matrix exhibited prolonged contractions and poor relaxation. This outcome suggests that extracellular matrix abnormalities must be addressed in therapies targeting established Transform on binned and centered pixels to calculate the power distribution (12, 13) .
We quantified alignment as the anisotropy align-
, where the lambdas are the eigenvalues of the Cartesian fiber orientation tensor (12) . To quantify the fibrosis fraction, both collagen content and total tissue content were segmented from either the MTR-or SR-stained tissue. The tissue and collagen segmentations were binarized by using the maximum entropy method in ImageJ, and the positive pixels were counted by using a custom MATLAB script; the fibrosis/tissue fraction was determined as the fraction of collagen pixels over total tissue pixels similar to published methods (14) .
MAINTENANCE AND CARDIAC DIFFERENTIATION
OF HUMAN iPSCs. The iPSCs used in this study were derived from T cells from a healthy adult man, previously described and extensively characterized (15) . Media changes with RPMI/B27 (-) insulin were performed every 2 days until spontaneous beating was observed (usually between days 7 and 11 of differentiation), after which the medium was changed to RPMI/B27 (þ) insulin. iPSC-CMs were used to create engineered heart tissues (EHTs) on day 14 after the start of differentiation.
EHT MANUFACTURING AND FUNCTIONAL TESTING.
EHTs made out of decellularized myocardium were created similar to our previously published protocol (15) . Briefly, we cut 150 mm slices from age-matched WT and mutant MYH7 R403Q porcine left ventricular blocks (MUT), which were frozen as discussed ( Figure 1A) . We omitted the sterilization process using peracetic acid and instead cultured the tissues in Dulbecco's modified Eagle medium with 10% fetal bovine serum and 2% penicillin-streptomycin overnight before seeding them the next day. For this study, we seeded both groups with exactly the same cell suspension at the same time. Active contraction mechanics were assessed as previously described (15) using a World Precision Instruments (WPI KG7) force transducer ( Figure 1B 17 mg/ml Fura 2-AM, 0.2% Pluronic F127, and 0.5%
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Cremophor EL) and subsequently imaged at 35 C using a photometric system as previously described.
EHTs were paced at 1 Hz during both contractile and calcium testing.
UNIAXIAL DIASTOLIC/PASSIVE MECHANICS. EHTs and tissue samples were brought to culture length (6.0 mm) on our apparatus at physiological pH (7.3) and temperature (36 C) and preconditioned for 3 cy- Complementary deoxyribonucleic acid (cDNA) was synthesized by using an iScript cDNA synthesis Kit (Bio-Rad, Hercules, California) according to the manufacturer's instructions. Quantitative polymerase chain reaction amplifications were performed by using an IQ TM SYBR green supermix (Bio-Rad) with a total reaction volume of 15 ml, containing 1 ml of cDNA, 1.5 ml of primers, and 5 ml of distilled water, on a CFX96TM Real-Time System (Bio-Rad) using conditions of 95 C for 3 min followed by 46 amplification cycles (95 C for 10 s, 58 C for 10 s, and 72 C for 30 s).
GAPDH was used as the reference gene in accordance with previous research (15 Sewanan et al.
A U G U S T 2 0 1 9 : 4 9 5 -5 0 5 No overt cardiac hypertrophy was observed in these tissues; however, the occurrence of tissue remodeling and concomitant cardiac dysfunction before the development of myocardial hypertrophy and increased left ventricular wall thickness is consistent with both a previous study in this large animal model (10) and in human studies (9, (20) (21) (22) (23) (24) (25) . We hypothesized that the moderate interstitial fibrosis and modest fiber disarray discerned through histological analysis of the mutant tissues would result in alterations of the passive properties of the mutant myocardium.
PASSIVE MECHANICS OF NATIVE TISSUE. Our EHTs allow us to perform uniaxial mechanical experiments.
To determine whether the R403Q mutation leads to adverse remodeling ultimately changing uniaxial stiffness in native cardiac ECM, we used our cassette system to perform simple uniaxial characterization ( Figure 3 ). In the native porcine samples ( Figure 3D ), exhibited a statistically significant increase in fibrosis fraction in MUT samples (n ¼ 11) compared with WT samples (n ¼ 18). ****p < 0.0001.
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Effects of Diseased Myocardial ECM on Cardiomyocyte Twitch Dynamics Table 1 ). No significant differences were observed in expression of these genes between WT and MUT EHTs (Supplemental Figure 3) .
DISCUSSION
To the best of our knowledge, the data presented here are the first to show the ability of diseased myocardial ECM to provoke abnormal contractile behavior in 
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Sewanan et al. Given the stark difference in matrix stiffness between HCM and control hearts, the observed contractility differences are not entirely surprising (37, 38 Future research should investigate modalities to reverse ECM remodeling to treat established HCM.
